Cite
Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction
MLA
Anthony J. Perissinotti, et al. “Successful Use of Blinatumomab in a Patient with Acute Lymphoblastic Leukemia and Severe Hepatic Dysfunction.” Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 26, no. 1, Feb. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2528e540a349490d2009861c018d1aa7&authtype=sso&custid=ns315887.
APA
Anthony J. Perissinotti, Kristen Pettit, Adam C Robinson, & Bernard L. Marini. (2019). Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 26(1).
Chicago
Anthony J. Perissinotti, Kristen Pettit, Adam C Robinson, and Bernard L. Marini. 2019. “Successful Use of Blinatumomab in a Patient with Acute Lymphoblastic Leukemia and Severe Hepatic Dysfunction.” Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 26 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2528e540a349490d2009861c018d1aa7&authtype=sso&custid=ns315887.